Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Matteucci

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2018
<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patientsPaola Caroli, Israel Sandler, Federica Matteucci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2018
Investigation of receptor radionuclide therapy with <sup>177</sup>Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation indexSilvia Nicolini, Stefano Severi, Annarita Ianniello, et al.
Archiv Der Pharmazie|July 26, 2024
New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2Gianfabio Giorgioni, Alessandro Bonifazi, Rosanna Matucci, et al.
Plos One|August 15, 2017
Quantitative accuracy of 177Lu SPECT imaging for molecular radiotherapyEmilio Mezzenga, Vincenzo D'Errico, Marco D'Arienzo, et al.
Oncotarget|December 16, 2014
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneUgo De Giorgi, Paola Caroli, Salvatore L Burgio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2017
Reduction of <sup>68</sup>Ga-PSMA renal uptake with mannitol infusion: preliminary resultsFederica Matteucci, Emilio Mezzenga, Paola Caroli, et al.
Therapeutic Advances in Medical Oncology|March 12, 2021
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imagingVincenza Conteduca, Giulia Poti, Paola Caroli, et al.
Journal of Cancer|June 7, 2012
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and ChemotherapyGiovenzio Genestreti, Andrea Moretti, Sara Piciucchi, et al.
Technology in Cancer Research & Treatment|June 20, 2014
Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot ExperienceGiovenzio Genestreti, Marco Angelo Burgio, Federica Matteucci, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 21, 2018
<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patientsPaola Caroli, Israel Sandler, Federica Matteucci, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 2, 2018
Investigation of receptor radionuclide therapy with <sup>177</sup>Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation indexSilvia Nicolini, Stefano Severi, Annarita Ianniello, et al.
Archiv Der Pharmazie|July 26, 2024
New potent muscarinic receptor ligands bearing the 1,4-dioxane nucleus: Investigation on the nature of the substituent in position 2Gianfabio Giorgioni, Alessandro Bonifazi, Rosanna Matucci, et al.
Plos One|August 15, 2017
Quantitative accuracy of 177Lu SPECT imaging for molecular radiotherapyEmilio Mezzenga, Vincenzo D'Errico, Marco D'Arienzo, et al.
Oncotarget|December 16, 2014
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abirateroneUgo De Giorgi, Paola Caroli, Salvatore L Burgio, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 13, 2017
Reduction of <sup>68</sup>Ga-PSMA renal uptake with mannitol infusion: preliminary resultsFederica Matteucci, Emilio Mezzenga, Paola Caroli, et al.
Therapeutic Advances in Medical Oncology|March 12, 2021
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imagingVincenza Conteduca, Giulia Poti, Paola Caroli, et al.
Journal of Cancer|June 7, 2012
FDG PET/CT Response Evaluation in Malignant Pleural Mesothelioma Patients Treated with Talc Pleurodesis and ChemotherapyGiovenzio Genestreti, Andrea Moretti, Sara Piciucchi, et al.
Technology in Cancer Research & Treatment|June 20, 2014
Endobronchial/Endoesophageal Ultrasound (EBUS/EUS) Guided Fine Needle Aspiration (FNA) and 18F-FDG PET/CT Scanning in Restaging of Locally Advanced Non-small Cell Lung Cancer (NSCLC) Treated with Chemo-radiotherapy: A Mono-institutional Pilot ExperienceGiovenzio Genestreti, Marco Angelo Burgio, Federica Matteucci, et al.
Pageof 8